Advertisement

Topics

Active Biotech AB Interim report January - March 2018

12:00 EDT 17 May 2018 | GlobalNewsWire (2014)

This article has expired, however you can still download the PDF.
Preview:
         First quarter in brief Decision on new share issue with preferential rights for shareholders taken at Extraordinary General Meeting on March 19, 2018 Patent application for tasquinimod for the treatment of multiple m...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Active Biotech AB Interim report January - March 2018 "

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...